Asim Farooq to Immunoconjugates
This is a "connection" page, showing publications Asim Farooq has written about Immunoconjugates.
Connection Strength
0.414
-
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma. JAMA Ophthalmol. 2025 06 01; 143(6):507-514.
Score: 0.211
-
Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies. Oncologist. 2024 Nov 04; 29(11):e1435-e1451.
Score: 0.203